Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07250139 · ClinicalTrials.gov registry record · NA
Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation
A NA study of Ptosis, Eyelid and Blepharoplasty, sponsored by Osheru.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07250139 is a NA study of Ptosis, Eyelid and Blepharoplasty that is actively recruiting participants, run by Osheru. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07250139, a NA study of Ptosis, Eyelid and Blepharoplasty, is actively recruiting participants, sponsored by Osheru.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two surgery techniques used for upper eyelid (eyelift) surgery: traditional surgery and a newer method called Ziplyft (a non-powered, hand-held clamp). This study will use a "split-face" design, meaning one eyelid will be treated with the traditional surgery method and the other with Ziplyft, allowing a direct side-by-side comparison. The objectives of the study are to compare Ziplyft treatment vs. traditional surgery by evaluating bruising, wound closure and incision, surgery case time, and subject/surgeon surveys.
Conditions Studied
Interventions
- DEVICE Ziplyft Device
- OTHER Comparator Arm: Standard Blepharoplasty
Study Locations (1)
North Carolina
- New Century Ophthalmology - Oxford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07250139
The ClinicalTrials.gov registry entry for NCT07250139 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Osheru, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ptosis, Eyelid appearing as the primary indexed condition, and to 2 interventions - of which Ziplyft Device is the first listed.
NCT07250139 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07250139 about?
NCT07250139 is a clinical study titled "Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation". This study will compare two surgery techniques used for upper eyelid (eyelift) surgery: traditional surgery and a newer method called Ziplyft (a non-powered, hand-held clamp). This study will use a "split-face" design, meaning one eyelid will be treated with the traditional surgery method and the ot...
What is the current status of trial NCT07250139?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-08. Estimated completion is 2026-09-30.
What conditions does trial NCT07250139 study?
This clinical trial studies the following conditions: Ptosis, Eyelid, Blepharoplasty, Dermatochalasis of Upper Eyelid.
What interventions are being tested in trial NCT07250139?
The interventions under investigation include: Ziplyft Device (DEVICE), Comparator Arm: Standard Blepharoplasty (OTHER).
Who is sponsoring clinical trial NCT07250139?
This trial is sponsored by Osheru, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07250139 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ptosis, Eyelid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.